SF
BLFS icon

Synovus Financial’s BioLife Solutions BLFS Stock Holding History

Synovus Financial’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-60
Closed -$1K – 2133
2019
Q4 		$1K Hold
60
– – ﹤0.01% 1473
2019
Q3 		$1K Hold
60
– – ﹤0.01% 1413
2019
Q2 		$1K Buy
+60
New +$1.05K ﹤0.01% 1337

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
SPA
Sentinel Pension Advisors Wakefield, Massachusetts $676M AUM 15.31% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
SCM
Sandler Capital Management New York $193M AUM 77.14% 1-Year Est. Return

Synovus Financial's BLFS Position: Q1 2020 in Review

Synovus Financial sold out of BioLife Solutions (BLFS) in Q1 2020, closing a stake of 60 shares — an estimated $1K sold.

Synovus Financial first reported a position in BLFS in Q2 2019 and held it in 3 quarters. The position peaked at $1K in Q4 2019. 75 funds tracked by Wall St. Rank hold BLFS as of Q1 2020.

  • Synovus Financial reported no remaining BioLife Solutions position as of Q1 2020 after selling out during the quarter.
  • Synovus Financial sold 60 BioLife Solutions shares in Q1 2020, an estimated $1K.
  • Synovus Financial first reported a position in BioLife Solutions in Q2 2019 and held it in 3 quarters.
  • Synovus Financial's BioLife Solutions position peaked at $1K in Q4 2019.
  • 75 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2020.

Based on Synovus Financial's 13F filing for Q1 2020, filed 24 Apr 2020.